Helen Of Troyの空売り状況は、投資家がHelen Of Troyの株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

Helen Of Troy (NASDAQ:HELE) 株価情報, 空売り情報

Helen Of Troy

Helen Of Troy Ltd is a consumer products company offering creative products and solutions for its customers through a diversified portfolio of brands. It has two operating segments: Home & Outdoor segment provides a broad range of consumer products for home activities such as food preparation, cooking, cleaning, and organization; as well as products for outdoor and on-the-go activities such as hydration, food storage, backpacks, and travel gear, and The Beauty & Wellness segment provides beauty and wellness products including mass and prestige market beauty appliances, prestige market liquid-based hair and personal care products, and wellness devices including thermometers, water and air filtration systems, humidifiers, and fans.

Helen Of Troy Ltd

HELENS INTL HLDG U/ADR by Helens International Holdings Company Limited

Helen Of Troy Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HELE#NASDAQ">HELE</a>) shares traded lower premarket on Wednesday after the company reported third-quarter earnings.
The company posted a third-quarter sales decline of 3.4% year-on-year to $530.706 million, missing the analyst <a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/b42869455/helen-of-troy-limited-reports-third-quarter-fiscal-2025-results" rel="noreferrer noopener">consensus estimate of $534.31 million</a>.
The decrease in sales was primarily driven by a decline in sales of Beauty &amp; Wellness.
Total net sales revenue for the Home &amp; Outdoor segment increased 4.3% and Beauty &amp; Wellness plunged 9.3%. Adjusted EPS of $2.67 <a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">beat the analyst consensus estimate of $2.60.</a>
Gross profit margin increased 90 basis points to 48.9%. The operating margin contracted 530 basis points to 14.2%, and operating income for the quarter decreased 29.7% to $75.1 million.
Non-GAAP adjusted EBITDA decreased 1% to $96.8 million, with a margin of 18.2% compared to 17.8%.
As of quarter-end, the company held $40.8 million in cash and equivalents. Operating cash flow for nine months totaled $78.2 million, with a free cash flow of $56.1 million, both down year over year.
&#8220;Beauty &amp; Wellness was negatively impacted by a weak illness season globally, including the weakest in the U.S. in the past eight years (excluding the COVID anomaly year of 2020-2021) and continued softness in Beauty,&#8221; said CEO Noel M. Geoffroy.
Inventory was $450.7 million versus $426 million in the third quarter of 2024. Helen Of Troy reaffirmed a one-time pre-tax restructuring charge of approximately $50 million – $55 million over the duration of Project Pegasus, expected to be completed during fiscal 2025.
Outlook: Helen Of Troy lowered the FY25 revenue outlook from <a target="_blank" href="https://www.benzinga.com/news/earnings/24/10/41249037/helen-of-troy-stock-crushes-q2-expectations-despite-beauty-wellness-setback" rel="noreferrer noopener">$1.885 billion – $1.935 billion</a> to $1.888 billion &#8211; $1.913 billion against an estimate of $1.924 billion.
HELE revised its FY25 adjusted EPS outlook from $7.00 – $7.50 to $7.15 &#8211; $7.40 versus an estimate of $7.21.
It revised FY25 adjusted EBITDA guidance from $287 million-$297 million to $292 million &#8211; $295 million.
Price Action: HELE shares are trading lower by 4.06% at $56.88 in premarket at the last check on Wednesday.

Earnings

Equities

News

Guidance

Movers

General

HELE

Helen Of Troy Sales Decline As Beauty Products Demand Softens; Shares Plunge

Helen Of Troy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HELE#NASDAQ">HELE</a>) reported quarterly earnings of $2.67 per share which beat the analyst consensus estimate of $2.60 by 2.69 percent. The company reported quarterly sales of $530.706 million which missed the analyst consensus estimate of $534.311 million by 0.67 percent. This is a 3.44 percent decrease over sales of $549.614 million the same period last year.

Earnings Beats

Earnings Misses

CORRECTION: Helen Of Troy Q3 2025 Adj. EPS $2.67 Beats $2.60 Estimate, Sales $530.706M Miss $534.311M Estimate

Helen Of Troy Narrows FY15 Adj EPS Outlook To $7.15-$7.40  from $7.00 - $7.50 Vs. $7.19 Est.

Helen Of Troy Sees Lowers FY25 Revenue Outlook To $1.888B - $1.913B Vs. $1.91B Est.

<h3>Companies Reporting Before The Bell</h3>
• UniFirst (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNF#NYSE">UNF</a>) is estimated to report quarterly earnings at $2.21 per share on revenue of $606.60 million. 
• Simply Good Foods (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMPL#NASDAQ">SMPL</a>) is projected to report quarterly earnings at $0.46 per share on revenue of $347.32 million. 
• Helen Of Troy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HELE#NASDAQ">HELE</a>) is likely to report quarterly earnings at $2.58 per share on revenue of $532.91 million. 
• MSC Industrial Direct Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSM#NYSE">MSM</a>) is likely to report quarterly earnings at $0.73 per share on revenue of $904.59 million. 
• Albertsons Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACI#NYSE">ACI</a>) is estimated to report quarterly earnings at $0.66 per share on revenue of $18.82 billion. 
• Acuity Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AYI#NYSE">AYI</a>) is estimated to report quarterly earnings at $3.89 per share on revenue of $956.17 million. 
• AngioDynamics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANGO#NASDAQ">ANGO</a>) is expected to report quarterly loss at $0.11 per share on revenue of $70.93 million. 
<h3>Companies Reporting After The Bell</h3>
• Jefferies Financial Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JEF#NYSE">JEF</a>) is likely to report quarterly earnings at $1.04 per share on revenue of $1.83 billion. 
• Penguin Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PENG#NASDAQ">PENG</a>) is expected to report quarterly earnings at $0.39 per share on revenue of $319.99 million. 
• Pricesmart (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSMT#NASDAQ">PSMT</a>) is projected to report quarterly earnings at $1.29 per share on revenue of $1.24 billion. 
• Greenbrier Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GBX#NYSE">GBX</a>) is projected to report quarterly earnings at $1.15 per share on revenue of $849.51 million. 
• Franklin Covey (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FC#NYSE">FC</a>) is estimated to report quarterly earnings at $0.22 per share on revenue of $70.15 million. 
• Saratoga Investment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAR#NYSE">SAR</a>) is projected to report quarterly earnings at $0.84 per share on revenue of $34.90 million. 
• Pure Cycle (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCYO#NASDAQ">PCYO</a>) is likely to report earnings for its first quarter. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ANGO

PCYO

Penguin Solutions, Inc. - Ordinary Shares

PENG

PSMT

SMPL

Earnings Scheduled For January 8, 2025

UBS analyst Peter Grom maintains Helen Of Troy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HELE#NASDAQ">HELE</a>) with a Neutral and lowers the price target from $79 to $69.

Price Target

Analyst Ratings

UBS Maintains Neutral on Helen Of Troy, Lowers Price Target to $69

The Company originally scheduled the release of its third quarter fiscal 2025 results before market open on January 9, 2025. This change reflects the observance of the National Day of Mourning in recognition of the passing of former President Jimmy Carter.

Helen Of Troy Reschedules Release Its Q3 Results To January 8, 2025

4 analysts have shared their evaluations of Helen Of Troy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HELE#NASDAQ">HELE</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Helen Of Troy, revealing an average target of $81.25, a high estimate of $92.00, and a low estimate of $71.00. Surpassing the previous average price target of $76.50, the current average has increased by 6.21%.
<img src="https://www.benzinga.com/files/images/story/2024/1732557654_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Helen Of Troy. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Linda Bolton Weiser</td>
<td>DA Davidson</td>
<td>Raises</td>
<td>Neutral</td>
<td>$78.00</td>
<td>$71.00</td>
</tr>
<tr>
<td>Linda Bolton Weiser</td>
<td>DA Davidson</td>
<td>Raises</td>
<td>Neutral</td>
<td>$71.00</td>
<td>$67.00</td>
</tr>
<tr>
<td>Susan Anderson</td>
<td>Canaccord Genuity</td>
<td>Raises</td>
<td>Buy</td>
<td>$92.00</td>
<td>$84.00</td>
</tr>
<tr>
<td>Susan Anderson</td>
<td>Canaccord Genuity</td>
<td>Maintains</td>
<td>Buy</td>
<td>$84.00</td>
<td>$84.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Helen Of Troy. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Helen Of Troy compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Helen Of Troy's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Capture valuable insights into Helen Of Troy's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/HELE/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Helen Of Troy analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>Get to Know Helen Of Troy Better</h2>
Helen Of Troy Ltd is a consumer products company offering creative products and solutions for its customers through a diversified portfolio of brands. It has two operating segments: Home &amp; Outdoor segment provides a broad range of consumer products for home activities such as food preparation, cooking, cleaning, and organization; as well as products for outdoor and on-the-go activities such as hydration, food storage, backpacks, and travel gear, and The Beauty &amp; Wellness segment provides beauty and wellness products including mass and prestige market beauty appliances, prestige market liquid-based hair and personal care products, and wellness devices including thermometers, water and air filtration systems, humidifiers, and fans.
<h3>Helen Of Troy: Financial Performance Dissected</h3>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Decline in Revenue: Over the 3 months period, Helen Of Troy faced challenges, resulting in a decline of approximately -3.53% in revenue growth as of 31 August, 2024. This signifies a reduction in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Consumer Discretionary sector.
Net Margin: Helen Of Troy's net margin excels beyond industry benchmarks, reaching 3.59%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Helen Of Troy's ROE stands out, surpassing industry averages. With an impressive ROE of 1.09%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Helen Of Troy's ROA excels beyond industry benchmarks, reaching 0.6%. This signifies efficient management of assets and strong financial health.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.48.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

The Latest Analyst Ratings For Helen Of Troy

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Loop Capital cut the price target for Warner Music Group Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WMG#NASDAQ">WMG</a>) from $38 to $35. Loop Capital analyst Alan Gould maintained a Hold rating. Warner Music shares closed at $31.85 on Friday. <a href="https://www.benzinga.com/quote/WMG/analyst-ratings">See how other analysts view this stock.</a></li>
<li>DA Davidson raised the price target for Helen of Troy Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HELE#NASDAQ">HELE</a>) from $71 to $78. DA Davidson analyst Linda Bolton Weiser maintained a Neutral rating. Helen of Troy shares closed at $69.92 on Friday. <a href="https://www.benzinga.com/quote/HELE/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>TD Cowen boosted Domino&#8217;s Pizza, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DPZ#NYSE">DPZ</a>) price target from $475 to $515. TD Cowen analyst Andrew Charles maintained a Buy rating. Domino&#8217;s shares settled at $453.35 on Friday. <a href="https://www.benzinga.com/quote/DPZ/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Canaccord Genuity boosted MicroStrategy Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) price target from $300 to $510. Canaccord Genuity analyst Joseph Vafi maintained a Buy rating. MicroStrategy shares closed at $421.88 on Friday. <a href="https://www.benzinga.com/quote/MSTR/analyst-ratings">See how other analysts view this stock.</a></li>
<li>B of A Securities raised Palantir Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>) price target from $55 to $75. B of A Securities analyst Mariana Perez maintained a Buy rating. Palantir shares closed at $64.35 on Friday.  <a href="https://www.benzinga.com/quote/PLTR/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Baird boosted Wix.com Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WIX#NASDAQ">WIX</a>) price target from $175 to $215. Baird maintained a Neutral rating on the stock. Wix shares closed at $217.20 on Friday. See how other analysts view this stock.</li>
<li>Wells Fargo cut the price target for HCA Healthcare, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACM#NYSE">ACM</a>) from $400 to $320. Wells Fargo analyst Stephen Baxter downgraded the stock from Equal-Weight to Underweight. HCA Healthcare shares settled at $324.93 on Friday. <a href="https://www.benzinga.com/quote/HCA/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Citigroup boosted U.S. Bancorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USB#NYSE">USB</a>) price target from $49 to $65. Citigroup analyst Keith Horowitz upgraded the stock from Neutral to Buy. U.S. Bancorp shares closed at $52.49 on Friday. <a href="https://www.benzinga.com/quote/USB/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Wedbush increased the price target for Salesforce, Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRM#NYSE">CRM</a>) from $325 to $375. Wedbush analyst Daniel Ives maintained an Outperform rating. Salesforce shares closed at $342.02 on Friday. <a href="https://www.benzinga.com/quote/CRM/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>DA Davidson boosted The Procter &amp; Gamble Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>) price target from $160 to $209. DA Davidson analyst Linda Bolton Weiser upgraded the stock from Neutral to Buy. Procter &amp; Gamble shares closed at $176.28 on Friday. <a href="https://www.benzinga.com/quote/PG/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Read This Next:
<ul>
<li> <a href="https://www.benzinga.com/24/11/42137942/jim-cramer-says-this-stock-is-a-bitcoin-play-and-he-prefers-to-own-bitcoin">Jim Cramer Says This Stock Is A Bitcoin Play And He Prefers To Own Bitcoin</a></li>
</ul>

Markets

Trading Ideas

MSTR

PLTR

Salesforce To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Monday

DA Davidson analyst Linda Bolton Weiser maintains Helen Of Troy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HELE#NASDAQ">HELE</a>) with a Neutral and raises the price target from $71 to $78.

DA Davidson Maintains Neutral on Helen Of Troy, Raises Price Target to $78

The acquisition is expected to be immediately accretive to Helen of Troy's revenue growth rate, gross profit margin, adjusted EBITDA margin, adjusted diluted EPS growth rate and free cash flow conversion. The Company expects its pro forma net leverage ratio(5) to be 3x or less at the estimated time of closing.
Olive &amp; June, founded in 2013, is an innovative, omni-channel nail care brand trailblazing the DIY nail revolution.&nbsp;

Helen Of Troy Enters Definitive Merger Agreement To Acquire The Business Of Olive & June, LLC For Total Purchase Consideration To Be $225M In Cash At Closing And $15M Earnout

There is a significant shift in institutional activity for Helen of Troy (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hele#NASDAQ">HELE</a>) shares. The institutions shifted from selling to buying in Q3, creating a solid tailwind due to the high interest. Institutions own nearly 99% of this stock, leaving less than 1.5% for insiders, retail investors, and short-sellers. Coincidentally, the short interest is also high, over 10% in the last report and nearly 10% in mid-September, providing ample fuel for a short-covering rally.&nbsp;
The takeaway for investors is that consumer products maker Helen of Troy has hit its market bottom and is now set to rebound. The rebound will likely take time to develop but will deliver sufficient upside to make this investment more than interesting. Trading near a decade low, technical targets for the stock price suggest a nearly 50% upside with a chance for a full reversal. In that scenario, the stock could gain another 50% to 100% over the next few years.&nbsp;
Insider activity is also noteworthy&mdash;not because of its volume but because of its lack thereof. Data from Insidertrades.com shows that insiders haven&#39;t sold or purchased this stock since 2023, the last being CFO Brian L. Grass&#39;s purchase. The lack of sales is a sign of insider confidence; investors should not be surprised if insiders start buying shares at such low levels.&nbsp;
<h2>Helen of Troy Outperforms in FQ2: Shares Surge</h2>
Helen of Troy continues to face challenges, including macroeconomic headwinds and efforts to improve efficiency. However, the Q2 results reflect a positive impact of the company&#39;s global restructuring effort named Project Pegasus. The Q2 revenue is down compared to last year but 330 basis points better than expected, with greater strength on the bottom line. The revenue decline is due to weakness in the Beauty and Wellness segments, offset by Home and Outdoors growth. Home and Outdoors sales grew nearly 1.0% despite negative product mix shifts, while Beauty and Wellness contracted by 7.7%.&nbsp;
Margin news is equally good. The company&#39;s margin contracted at the gross and operational levels in the GAAP and adjusted comparisons but was less than expected. The gross margin fell by 110 bps and the adjusted operating margin by 260, leaving the operating margin at 9.8%. The salient detail is that the 9.8% adjusted margin left the earnings down by double-digits, but the $1.21 in adjusted EPS is 1500 basis points ahead of the consensus estimate, providing sufficient cash flow to sustain operations, reinvestment, and capital return.
Guidance is mixed but indicates a turning point for the business. The company reaffirmed its full-year targets for revenue and earnings, which puts revenue in alignment with the consensus estimate and the EPS midpoint above it. The negative detail is that the free cash flow and debt reduction targets were eased but there is a mitigating factor. Operational challenges at the Tennessee distribution facility impact the cash flow. The automation effort hit snags in Q1, but remediation efforts have been largely completed. The impact on cash flow will end before the fiscal year-end, and automation is expected to drive additional efficiency in calendar 2025.&nbsp;
<h2>Helen of Troy Has a Fortress Balance Sheet</h2>
Helen of Troy has hurdles to cross but is in a position to do so. The balance sheet highlights include steady assets, declining debt, low leverage, and improving shareholder equity despite debt reduction and capital return. The capital return, in the form of share buybacks, ramped in Q2 compared to last year, reducing the average count by 5%.&nbsp;
The pace of buybacks is expected to continue in F2025 because of the recently announced increase in authorization. The new total is $500 million, which is a tailwind for the market because it is worth 35% of the market cap with shares at a ten-year low. Regarding leverage, total liability, including long-term debt, is about 1x equity.&nbsp;
Following the report, Helen of Troy shares surged nearly 20% in premarket trading. The move suggests that short-covering has begun and a bottom is in play. The critical resistance target is near $75 and the 150-day EMA; a sustained rally may soon form if the market moves above it. If not, the market may become range-bound at current levels until more news is available.&nbsp;
<img alt="Helen of Troy HELE stock chart" class="aligncenter" src="https://www.marketbeat.com/logos/articles/med_20241009082638_chart-hele-1092024.png" style="height:423px; width:917px" />
The article &quot;<a href="https://www.insidertrades.com/education/insiders-hold-tight-as-helen-of-troy-prepares-for-a-major-rebound/">Insiders Hold Tight as Helen of Troy Prepares for a Major Rebound</a>&quot; first appeared on MarketBeat.

Macro Economic Events

Short Sellers

Technicals

Contracts

Buybacks

Small Cap

Insider Trades

Economics

Insiders Hold Tight as Helen of Troy Prepares for a Major Rebound

DA Davidson analyst Linda Bolton Weiser maintains Helen Of Troy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HELE#NASDAQ">HELE</a>) with a Neutral and raises the price target from $67 to $71.

DA Davidson Maintains Neutral on Helen Of Troy, Raises Price Target to $71

Canaccord Genuity analyst Susan Anderson maintains Helen Of Troy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HELE#NASDAQ">HELE</a>) with a Buy and raises the price target from $84 to $92.

Canaccord Genuity Maintains Buy on Helen Of Troy, Raises Price Target to $92

Helen of Troy Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hele#NASDAQ">HELE</a>) posted second-quarter fiscal 2025 results, wherein both the top and bottom lines declined year over year. However, both metrics beat the Zacks Consensus Estimate.
During the quarter, management advanced its long-term strategies by strengthening the core business and reshaping the growth portfolio. Despite ongoing macroeconomic challenges, the company achieved early success with its &#39;Reset and Revitalize&#39; initiative, driven by stronger brand fundamentals, refined marketing and innovation efforts and expanded distribution.
<h2>HELE&#39;s Q2 in Detail</h2>
Adjusted earnings of $1.21 per share surpassed the Zacks Consensus Estimate of $1.08, delivering a positive surprise of around 12%. However, the bottom line declined 30.5% year over year due to reduced adjusted operating income and higher tax rates. These were somewhat countered by lower interest expenses and shares outstanding.
<div class="chart_embed">
<h3>Helen of Troy Limited Price, Consensus and EPS Surprise</h3>
<img alt="Helen of Troy Limited Price, Consensus and EPS Surprise" src="https://staticx-tuner.zacks.com/images/charts/05/1728481189.png" style="height:265px; width:576px" title="" />
Helen of Troy Limited price-consensus-eps-surprise-chart | Helen of Troy Limited Quote
Consolidated net sales of $474.2 million came ahead of the Zacks Consensus Estimate of $457 million. However, the metric fell 3.5% from the year-ago quarter&#39;s tally. This downtick was caused by reduced sales of hair appliances, humidifiers and air purifiers in the Beauty &amp; Wellness unit. This was partly compensated by growth in the home and insulated beverageware categories in the Home &amp; Outdoor segment. The decline in net sales was also partly mitigated by international expansion and increased sales of fans and thermometers within the Beauty &amp; Wellness category.
The consolidated gross profit margin contracted 110 basis points (bps) to 45.6% due to less favorable product and customer mixes within the Home &amp; Outdoor unit, partly made up by reduced commodity and product costs resulting from Project Pegasus initiatives.
The consolidated SG&amp;A ratio increased 140 basis points (bps) to 37.9%. The rise in such costs was due to increased spending on marketing, partly offset by reduced personnel costs.
The adjusted operating income declined 25.5% to $46.4 million, with the adjusted operating margin contracting 290 bps to 9.8%. Our model suggested an adjusted operating margin contraction of 360 bps.
</div>
<h2>HELE&#39;s Segmental Performance</h2>
Net sales in the Home &amp; Outdoor segment rose 0.8% to $241.9 million, fueled by greater insulated beverageware category sales and international sales. These were countered by weaker consumer demand, reduced replenishment orders from retail customers, and continued sluggishness in technical packs and related accessories.
Net sales in the Beauty &amp; Wellness segment declined 7.7% to $232.3 million. The decline was mainly caused by reduced sales of hair appliances stemming from softer consumer demand, changes in consumer spending habits and increased competition. Lower sales of humidifiers and air purifiers were due to lower orders from retail customers. There was also a decrease in water filtration product revenues due to the expiration of a licensing agreement. Nevertheless, these challenges were partly balanced by an increase in fan and thermometer sales. We expected Beauty &amp; Wellness net sales to decline 6.8% in the second quarter.
<h2>Other Details</h2>
Helen of Troy ended the quarter with cash and cash equivalents of $20.1 million and total short and long-term debt of $713.2 million. Net cash provided by operating activities for the first six months of fiscal 2025 was $69.9 million.&nbsp; The free cash flow for the same period was $55.9 million.
<h2>What to Expect From HELE in FY25?</h2>
For fiscal 2025, HELE anticipates consolidated net sales revenues to range between $1.885 billion and $1.935 billion, indicating a decline of 6% to 3.5% year over year. This sales outlook reflects ongoing concerns about persistent inflation and continued softness in consumer spending, particularly in certain discretionary product categories. The forecast also considers anticipated challenges in operational performance at the Tennessee distribution facility, along with heightened macroeconomic uncertainty. Management also anticipates a more competitive promotional environment and increased vigilance from retailers in managing their inventory levels.
In the Home &amp; Outdoor segment, net sales growth is now expected to range between a 2.3% decline and 1.4% growth compared to the earlier view of a 3-1% decline. The revised guidance includes shipping disruption impacts in the company&#39;s Tennessee distribution facility.
For the Beauty &amp; Wellness segment, net sales are projected to decline 9-7.5% now compared with an 8-5% decline expected before.
The company still envisions fiscal 2025 adjusted EPS to range from $7.00 to $7.50, indicating a decline of 15.8% to 21.4%. It expects adjusted EBITDA in the range of $287-$297 million, suggesting a fall of 11.8-14.6%. GAAP EPS is still expected between $4.69 and $5.45 in fiscal 2025.
The free cash flow is expected in the band of $180-$200 million now, down from the earlier view of $220-$240 million.
For the third quarter of fiscal 2025, the company expects sales to decline 1-4.5%. Management anticipates adjusted EPS to decline by 3-10% in the fiscal third quarter.
Shares of this Zacks Rank #3 (Hold) company have risen 1% in the past three months compared to the industry&#39;s 12.1% decline.
<h2>Three Staple Stocks Worth Betting On</h2>
The Chef&#39;s Warehouse (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/chef#NASDAQ">CHEF</a>), which engages in the distribution of specialty food products, currently carries a Zacks Rank #2 (Buy).
CHEF has a trailing four-quarter earnings surprise of 33.7%, on average. The Zacks Consensus Estimate for The Chef&#39;s Warehouse&#39;s current fiscal year sales and earnings indicates growth of 9.7% and 12.6%, respectively, from the year-ago reported numbers.
Flowers Foods (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/flo#NYSE">FLO</a>), a packaged bakery food company, currently carries a Zacks Rank #2. FLO has a trailing four-quarter earnings surprise of 1.9%, on average.
The Zacks Consensus Estimate for Flowers Foods&#39; current financial-year sales and earnings implies growth of around 1% and 5%, respectively, from the year-ago reported numbers.
McCormick (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mkc#NYSE">MKC</a>) is a leading manufacturer, marketer and distributor of spices, seasonings, specialty foods and flavors. It currently carries a Zacks Rank of 2.
The Zacks Consensus Estimate for McCormick &amp; Company&#39;s current fiscal-year earnings indicates an advancement of 5.9% from the year-ago reported figures. MKC has a trailing four-quarter earnings surprise of 13.8%, on average.
<a href="https://www.zacks.com/stock/news/2348407/helen-of-troy-q2-earnings-top-beauty-wellness-sales-decline-y-y?cid=CS-BENZ-FT-analyst_blog|earnings_article-2348407">To read this article on Zacks.com click here.</a>

Large Cap

Mid Cap

Retail Sales

Management

CHEF

Helen of Troy Q2 Earnings Top, Beauty & Wellness Sales Decline Y/Y

<h3>Gainers</h3>
<ul>
<li>Kaixin Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KXIN#NASDAQ">KXIN</a>) shares rose 48.3% to $0.27 during Wednesday's regular session. The company's market cap stands at $15.9 million. </li>
<li>WW International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WW#NASDAQ">WW</a>) shares increased by 42.97% to $1.66. The market value of their outstanding shares is at $132.2 million. </li>
<li>Helen Of Troy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HELE#NASDAQ">HELE</a>) stock increased by 19.23% to $74.36. The company's market cap stands at $1.6 billion. The company's, Q2 earnings came out today. </li>
<li>Container Store Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TCS#NYSE">TCS</a>) shares moved upwards by 16.9% to $10.79. The market value of their outstanding shares is at $37.1 million. </li>
<li>Nova Lifestyle (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVFY#NASDAQ">NVFY</a>) shares moved upwards by 16.89% to $1.54. The market value of their outstanding shares is at $4.7 million. </li>
<li>Luminar Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LAZR#NASDAQ">LAZR</a>) stock increased by 15.67% to $0.96. The market value of their outstanding shares is at $485.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Sacks Parente Golf (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPGC#NASDAQ">SPGC</a>) stock declined by 45.7% to $1.93 during Wednesday's regular session. The market value of their outstanding shares is at $2.8 million. </li>
<li>Ambow Education Holding (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AMBO#AMEX">AMBO</a>) shares decreased by 13.88% to $3.6. The company's market cap stands at $10.2 million. </li>
<li>Sunlands Technology (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STG#NYSE">STG</a>) stock fell 12.74% to $7.81. The company's market cap stands at $107.0 million. </li>
<li>QuantaSing Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QSG#NASDAQ">QSG</a>) stock declined by 10.26% to $3.59. The market value of their outstanding shares is at $183.4 million. </li>
<li>Kidpik (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PIK#NASDAQ">PIK</a>) stock declined by 9.59% to $1.98. The market value of their outstanding shares is at $3.8 million. </li>
<li>Digital Brands Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DBGI#NASDAQ">DBGI</a>) shares decreased by 9.22% to $0.19. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AMBO

DBGI

KXIN

LAZR

NVFY

SPGC

12 Consumer Discretionary Stocks Moving In Wednesday's Intraday Session

U.S. stocks were higher, with the Dow Jones index gaining around 0.2% on Wednesday.
Shares of Arcadium Lithium plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALTM#NYSE">ALTM</a>) rose sharply during Wednesday's session after the company <a href="https://www.benzinga.com/m-a/24/10/41250060/arcadium-lithium-stock-is-soaring-wednesday-whats-behind-the-move">announced it will be acquired by Rio Tinto.</a>
Rio Tinto and Arcadium Lithium entered into a definitive agreement under which Rio Tinto will acquire Arcadium in an all-cash transaction for $5.85 per share, valuing the company at approximately $6.7 billion.
Arcadium Lithium shares jumped 30.5% to $5.54 on Wednesday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>MicroCloud Hologram Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOLO#NASDAQ">HOLO</a>) shares surged 33.1% to $6.89.</li>
<li>Helen of Troy Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HELE#NASDAQ">HELE</a>) gained 20.6% to $75.22 after the company reported better-than-expected second-quarter financial results.</li>
<li>Astera Labs, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALAB#NASDAQ">ALAB</a>) shares jumped 15.7% to $61.31 after the company announced a new portfolio of fabric switches purpose-build for AI infrastructure at cloud-scale. Also, Morgan Stanley maintained an Overweight rating on the stock and raised its price target from $55 to $74.</li>
<li>Standard Lithium Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLI#NYSE">SLI</a>) surged 14.6% to $1.9788.</li>
<li>IDT Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IDT#NYSE">IDT</a>) gained 14.5% to $44.03.</li>
<li>Luminar Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LAZR#NASDAQ">LAZR</a>) climbed 10.7% to $0.9196.</li>
<li>Sigma Lithium Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGML#NASDAQ">SGML</a>) rose 9.4% to $14.44.</li>
<li>Biomea Fusion, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BMEA#NASDAQ">BMEA</a>) surged 9.3% to $12.46. EF Hutton analyst Jason Kolbert initiated coverage on Biomea Fusion with a Buy rating and announced a price target of $128.</li>
<li>Norwegian Cruise Line Holdings Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NCLH#NYSE">NCLH</a>) gained 8.1% to $22.48. Citigroup analyst James Hardiman upgraded Norwegian Cruise Line from Neutral to Buy and raised the price target from $20 to $30.</li>
<li>Array Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARRY#NASDAQ">ARRY</a>) rose 6.8% to $6.88.</li>
<li>Super Micro Computer, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) climbed 5.4% to $47.80.</li>
<li>GitLab Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTLB#NASDAQ">GTLB</a>) gained 5.3% to $52.60. Morgan Stanley analyst Sanjit Singh initiated coverage on GitLab with an Overweight rating and announced a price target of $70.</li>
<li>Chewy, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHWY#NYSE">CHWY</a>) rose 3.3% to $30.50. TD Cowen analyst Bill Kerr initiated coverage on Chewy with a Buy rating and announced a price target of $38.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/10/41238686/jim-cramer-ast-spacemobile-is-just-too-hot-recommends-buying-this-tech-stock">Jim Cramer: AST SpaceMobile Is &#8216;Just Too Hot,&#8217; Recommends Buying This Tech Stock</a></li>
</ul>

ALAB

ALTM

ARRY

BMEA

CHWY

GTLB

MicroCloud Hologram Inc. - Ordinary Shares

HOLO

NCLH

SGML

SMCI

Arcadium Lithium, Norwegian Cruise Line, GitLab, Chewy And Other Big Stocks Moving Higher On Wednesday

U.S. stocks traded mixed this morning, with the Dow Jones index gaining more than 100 points on Wednesday.
Following the market opening Wednesday, the Dow traded up 0.35% to 42,226.68 while the NASDAQ fell 0.20% to 18,146.90. The S&amp;P 500 also rose, gaining, 0.03% to 5,752.58.
Check This Out: <a href="https://www.benzinga.com/news/earnings/24/10/41249094/how-to-earn-500-a-month-from-jpmorgan-stock-ahead-of-q3-earnings">How To Earn $500 A Month From JPMorgan Stock Ahead Of Q3 Earnings</a>
Leading and Lagging Sectors Financials shares jumped by 0.5% on Wednesday.
In trading on Wednesday, communication services shares fell by 0.9%.
Top Headline
Helen Of Troy Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HELE#NASDAQ">HELE</a>) reported better-than-expected second-quarter results, reaffirming its FY25 sales and EPS outlook.
The company reported a second-quarter sales decline of 3.5% year-over-year to $474.221 million, beating the analyst consensus of $458.237 million. Adjusted EPS declined 34.1% YoY to $1.21, beating the consensus estimate of $1.04.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Momentus Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNTS#NASDAQ">MNTS</a>) shares shot up 91% to $0.7966 after the company announced a NASA contract to provide launch services for future agency missions.</li>
<li>Shares of Banzai International, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNZI#NASDAQ">BNZI</a>) got a boost, surging 80% to $4.9699 after the company announced strategic business initiatives to improve net income.</li>
<li>Inhibikase Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IKT#NASDAQ">IKT</a>) shares were also up, gaining 38% to $1.65 after the company announced the pricing of an approximately $110 million private placement financing.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Sacks Parente Golf, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPGC#NASDAQ">SPGC</a>) shares dropped 46% to $1.96 after gaining 35% after the company announced a $732K public offering of 366,000 shares of common stock for general corporate and working capital needs.</li>
<li>Shares of BAIYU Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BYU#NASDAQ">BYU</a>) were down 43% to $0.5712.</li>
<li>Alternus Clean Energy Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALCE#NASDAQ">ALCE</a>) was down, falling 37% to $0.0903 after the company announced a 1-for-25 reverse stock split as part of its Nasdaq compliance plan.</li>
</ul>
Commodities In commodity news, oil traded down 2.2% to $71.97 while gold traded down 0.3% at $2,627.90.
Silver traded up 0.2% to $30.645 on Wednesday, while copper fell 1.6% to $4.3870.
Euro zone
European shares were higher today. The eurozone's STOXX 600 rose 0.3%, Germany's DAX gained 0.5% and France's CAC 40 rose 0.3%. Spain's IBEX 35 Index fell 0.1%, while London's FTSE 100 rose 0.4%.
Germany&#8217;s trade surplus increased to EUR 22.5 billion in August versus a revised EUR 16.9 billion in the prior month, topping market estimates of EUR 18.4 billion.
Asia Pacific Markets
Asian markets closed mostly lower on Wednesday, with Japan's Nikkei 225 gaining 0.87%, Hong Kong's Hang Seng Index dipping 1.38%, China's Shanghai Composite Index falling 6.62% and India's BSE Sensex dipping 0.21%.
Japan's machine tool orders declined 6.5% year-over-year to JPY 125,297 million in September compared to a 3.5% decline in the prior month, while the Reuters Tankan sentiment index for manufacturers climbed to +7 in October versus +4 in September. The Reserve Bank of India maintained its benchmark policy repo rate at 6.5% during October meeting.
Economics
U.S. mortgage applications declined by 5.1% from the previous week during the first week of October, compared to a 1.3% drop in the prior week.
Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/10/41248833/jim-cramer-says-hes-buying-some-target-but-dismisses-soundhound-ai-as-meme-stock"> </a>
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/10/41248833/jim-cramer-says-hes-buying-some-target-but-dismisses-soundhound-ai-as-meme-stock">Jim Cramer Says He&#8217;s Buying &#8216;Some Target,&#8217; But Dismisses SoundHound AI As &#8216;Meme Stock</a><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/10/41248833/jim-cramer-says-hes-buying-some-target-but-dismisses-soundhound-ai-as-meme-stock">&#8216;</a></li>
</ul>
<a href="https://www.benzinga.com/trading-ideas/long-ideas/24/10/41248833/jim-cramer-says-hes-buying-some-target-but-dismisses-soundhound-ai-as-meme-stock">&nbsp;</a>

Eurozone

Commodities

ALCE

BNZI

MNTS

Dow Jumps Over 100 Points; Helen Of Troy Posts Upbeat Q2 Results

Helen Of Troy Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HELE#NASDAQ">HELE</a>) shares surged after the company reported better-than-expected <a target="_blank" href="https://www.benzinga.com/pressreleases/24/10/b41246445/helen-of-troy-limited-reports-second-quarter-fiscal-2025-results" rel="noreferrer noopener">second-quarter results, reaffirming its FY25 sales and EPS outlook</a>.
The company reported a second-quarter sales decline of 3.5% year-over-year to $474.221 million, beating the analyst consensus of $458.237 million.
The decrease in sales was primarily driven by a decline in Beauty &amp; Wellness due to lower sales of hair appliances, air purifiers, and humidifiers.
Total net sales revenue for the Home &amp; Outdoor segment increased 0.8% year over year, while Beauty &amp; Wellness declined 7.7%.
Adjusted EPS declined 34.1% YoY to $1.21, <a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">beating the consensus estimate of $1.04.</a>
The gross profit margin decreased by 116 bps to 45.6%. The operating margin contracted 220 basis points to 7.3%, and operating income for the quarter declined 25.6% to $34.85 million.
Adjusted operating income decreased 25.5% to $46.4 million, and the margin fell to 9.8% from 12.7% year over year.
Non-GAAP adjusted EBITDA decreased 22.2% to $55.8 million, with the margin down to 11.8% compared to 14.6%.
As of August end, the company held $20.14 million in cash and equivalents. Operating cash flow for the six months totaled $69.92 million, compared to $157.73 million a year ago. Free cash flow totaled $55.89 million.
Inventory was $469.6 million, compared to $435.7 million in the second quarter of 2024.
Noel M. Geoffroy, CEO, commented: &#8220;We are pleased to report&nbsp;second quarter&nbsp;results that were above expectations and we are reaffirming our annual&nbsp;outlook&nbsp;for net sales, adjusted EPS, and adjusted EBITDA. During the quarter, we took decisive actions toward our long-term strategic initiatives, including strengthening the core and further shaping our growth portfolio.&#8221;
2025 Outlook: Helen Of Troy continues to expect consolidated net sales revenue in the range of $1.885 billion &#8211; $1.935 billion versus the consensus of $1.896 billion and adjusted EPS of $7.00 &#8211; $7.50 <a href="https://www.benzinga.com/calendars/guidance">versus the consensus of $7.12.</a>
The company continues to expect adjusted EBITDA of $287 million to $297 million, which implies a decline of 14.6% to 11.8%, as benefits from Project Pegasus are reinvested for growth.
HELE updates its free cash flow guidance to $180 million &#8211; $200 million, compared to the previous range of $200 million &#8211; $240 million. It now expects a net leverage ratio of 1.90x to 1.80x, compared to the prior range of 1.60x to 1.50x.
The company mentioned that Project Pegasus remains on track to achieve savings of $26 million to $30 million.
For the third quarter, the company expects a decline in net sales of 4.5%&nbsp;to&nbsp;1%&nbsp;and adjusted EPS decline&nbsp;of 10%&nbsp;to&nbsp;3%.
Price Action: HELE shares are trading higher by 12.6% at $70.21 premarket at the last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/10/41244306/s-p-gains-1-as-nvidia-broadcom-shares-surge-investor-optimism-improves-fear-index-remains-in-greed-" target="_blank" rel="noreferrer noopener">S&amp;P Gains 1% As Nvidia, Broadcom Shares Surge: Investor Optimism Improves, Fear Index Remains In &#8216;Greed&#8217; Zone</a></li>
</ul>

Helen Of Troy Stock Crushes Q2 Expectations Despite Beauty & Wellness Setback

WW: 56% &#x7C; <a href="https://www.benzinga.com//node/41248405">WW shares are trading higher after the company on Tuesday announced the addition of compounded semaglutide into its offering.</a>
&nbsp;
HELE: 17% &#x7C; <a href="https://www.benzinga.com//node/41246701">Helen of Troy shares are trading higher after the company reported better-than-expected Q2 financial results.</a>
&nbsp;
CLSD: 69% &#x7C; <a href="https://www.benzinga.com//node/41246215">Clearside Biomedical Says ODYSSEY Phase 2b Trial Of CLS-AX (Axitinib Injectable Suspension) For Neovascular Age-related Macular Degeneration Achieved Both Its Primary And Secondary Outcomes</a>

CLSD

Market-Moving News for October 9th

Check out this morning's top movers from around Wall Street, compiled by The Fly. HIGHER – LifeVantage (LFVN) up 33% after initiating Q2 and FY25 g...

Morning Movers: AngioDynamics jumps following results and guidance raise

Wall Street Lunch: Quantum Computing Stocks Under Pressure

Helen of Troy Limited (HELE) Q3 2025 Earnings Call Transcript

Wall Street Lunch: Nvidia Hamstrings Quantum Computing Stocks

Helen of Troy Plummets Again: Another Speculative Entry

Helen Of Troy ( ($HELE) ) has released its Q3 earnings. Here is a breakdown of the information Helen Of Troy presented to its investors. Helen of T...

Helen of Troy Reports Q3 Fiscal 2025 Performance

Analysts have been eager to weigh in on the Consumer Cyclical sector with new ratings on PUMA SE NPV (PMMAF – Research Report), Helen Of Troy (HELE...

Analysts Conflicted on These Consumer Cyclical Names: PUMA SE NPV (OtherPMMAF), Helen Of Troy (HELE) and Arhaus (ARHS)

Canaccord Genuity analyst Susan Anderson maintained a Buy rating on Helen Of Troy (HELE – Research Report) today and set a price target of $92.00. ...

Helen Of Troy: Strategic Initiatives and Acquisitions Drive a Buy Rating

Helen Of Troy (($HELE)) has held its Q3 earnings call. Read on for the main highlights of the call. The latest earnings call for Helen of Troy pres...

Helen of Troy Earnings Call: Growth Amid Challenges

Ugly day for beauty stocks after e.l.f. Beauty lowers guidance

ARHS

COTY

DKNG

FLUT

IGPT

INMD

IPAR

LFVN

NVDA

PDYPY

PMMAF

PROF

QUBT

SKIN

ULTA

Press Releases

PUR® Helps Families and Local Schools Respond to Lead Water Contamination Concerns Amid New EPA Regulations

Helen of Troy Limited Announces Agreement to Acquire Olive & June, LLC

Osprey Marks the Next Evolution in Winter Gear with 2025 Snow Line

Helen of Troy Completes Acquisition of Olive & June, LLC

Helen of Troy Limited Announces Earnings Release Date, Conference Call, and Webcast for Third Quarter Fiscal 2025 Results

Helen of Troy Limited Changes Earnings Release and Conference Call Date for Third Quarter Fiscal 2025 Results in Observance of the National Day of Mourning in Recognition of Former President Jimmy Carter

Helen of Troy Limited Reports Third Quarter Fiscal 2025 Results

Helen of Troy Limited Announces Participation in the ICR Conference 2025

Osprey Packs Balances Sustainability and Functionality for Fall 2025's Expanded Lifestyle Collection

Comments

Helen Of Troy

空売り

Helen Of Troy (NASDAQ:HELE) 株価情報, 空売り情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル